Paid Clinical Trials Cranston

Discover 461 paid clinical trials in Cranston, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 461

Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter StudySmart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study

Recruiting

Sponsor:

Children's Hospital of Philadelphia

Location:

Providence RI, Charlottesville VA, Akron OH, Atlanta GAshow 2 more

Code:

NCT06085326

Conditions

Intubation Complication

Eligibility Criteria

Sex: All

Age: 0 - 19

Healthy Volunteers: Not accepted

Interventions

Smart Checklist

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Recruiting

PHASE1

Sponsor:

Pfizer

Location:

Providence RI, Cleveland OH, Cincinnati OH, Grand Rapids MIshow 5 more

Code:

NCT06447662

Conditions

Carcinoma, Pancreatic Ductal

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07934040

Gemcitabine

Nab-paclitaxel

Cetuximab

Fluorouracil

mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIVmHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV

Recruiting

Sponsor:

Rhode Island Hospital

Location:

Providence RI, Atlanta GA

Code:

NCT05046392

Conditions

HIV

Medication Adherence

Telemedicine

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Face-to-Face ART Adherence Intervention

Carium Mobile Health Platform

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLCTo Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Recruiting

PHASE3

Sponsor:

Shanghai Henlius Biotech

Location:

Providence RI, Norwich CT, Boston MA, Burlington MAshow 85 more

Code:

NCT05468489

Conditions

Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serplulimab + chemotherapy (carboplatin-etoposide)

Atezolizumab + chemotherapy (carboplatin-etoposide)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Providence RI, Warwick RI, Westerly RI, Boston MAshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

Recruiting

PHASE1

Sponsor:

EMD Serono Research & Development Institute, Inc.

Location:

Providence RI, Ottawa, Toronto, Dallas TXshow 4 more

Code:

NCT05464030

Conditions

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

M9140

Bevacizumab

Capecitabine

5-fluorouracil (5-FU)

Folinic acid

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

Recruiting

PHASE3

Sponsor:

Hoffmann-La Roche

Location:

Providence RI, Boston MA, Scarborough ME, East Brunswick NJshow 55 more

Code:

NCT06065748

Conditions

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Giredestrant

Fulvestrant

Abemaciclib

Palbociclib

Ribociclib

tDCS to Decrease Opioid Relapse (UH3)tDCS to Decrease Opioid Relapse (UH3)

Recruiting

Sponsor:

Butler Hospital

Location:

Providence RI

Code:

NCT06432465

Conditions

Opioid Use Disorder

Eligibility Criteria

Sex: All

Age: 21 - 60

Healthy Volunteers: Not accepted

Interventions

active tDCS

sham tDCS

VeinViewer Assisted Intravenous Catheter Placement in the Pediatric Emergency DepartmentVeinViewer Assisted Intravenous Catheter Placement in the Pediatric Emergency Department

Recruiting

Sponsor:

Lifespan

Location:

Providence RI

Code:

NCT00468065

Conditions

Catheterization

Eligibility Criteria

Sex: All

Age: 0 - 17

Healthy Volunteers: Not accepted

Interventions

VeinViewer

Veinviewer

FX Shoulder Prospective Clinical StudyFX Shoulder Prospective Clinical Study

Recruiting

Sponsor:

FX Shoulder Solutions

Location:

Wakefield RI, Marietta OH, Bedford TX, Gilbert AZ

Code:

NCT06078865

Conditions

Osteoarthritis Shoulder

Rotator Cuff Syndrome of Shoulder and Allied Disorders

Fracture, Shoulder

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

FX Artificial Shoulder Prosthesis